New tuberculosis drug development: targeting the shikimate pathway

Author： Kapnick Senta M   Zhang Ying  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.5, 2008-05, pp. : 565-577

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Shikimate Kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: Kinetics and Structural Dynamics of a Potential Molecular Target for Drug Development

By  

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1299-1310

Bentham Science Publishers

Access to resources Recommend Favorite

Mycobacterial Shikimate Pathway Enzymes as Targets for Drug Design

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-01 ,pp. : 423-435

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Secretory Pathway for Anti-Inflammatory Drug Development

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-01 ,pp. : 165-178

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberculosis: Current Treatment and New Drug Development

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 5, Iss. 4, 2006-10 ,pp. : 331-344

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Histidine Pathway in Mycobacterium tuberculosis

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 22, 2013-11 ,pp. : 2866-2884

Bentham Science Publishers

Access to resources Recommend Favorite